Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kristen L. Arienti is active.

Publication


Featured researches published by Kristen L. Arienti.


Bioorganic & Medicinal Chemistry Letters | 1999

4-alkyl- and 3,4-dialkyl-1,2,3,4-tetrahydro-8-pyridono[5,6-g]quinolines : Potent, nonsteroidal androgen receptor agonists

Robert I. Higuchi; James P. Edwards; Thomas R. Caferro; Josef D. Ringgenberg; James Kong; Lawrence G. Hamann; Kristen L. Arienti; Keith B. Marschke; Robert L. Davis; Luc J. Farmer; Todd K. Jones

A series of human androgen receptor (hAR) agonists based on 4-alkyl-; 4,4-dialkyl-; and 3,4-dialkyl-1,2,3,4-tetrahydro-8-pyridono[5,6-g]quinoline was synthesized and evaluated in competitive receptor binding assays and an androgen receptor cotransfection assay in a mammalian cell background. A number of compounds in this series demonstrated activity equal to or better than dihydrotestosterone in both assays and represent a novel class of compounds for use in androgen replacement therapy.


Journal of Biological Chemistry | 2003

Inhibition of Fructose-1,6-bisphosphatase by a New Class of Allosteric Effectors

Jun-young Choe; Scott W. Nelson; Kristen L. Arienti; Frank U. Axe; Tassie L. Collins; Todd K. Jones; Rachel D.A. Kimmich; Michael J. Newman; Karl Norvell; William C. Ripka; Suzanne J. Romano; Kevin M. Short; Deborah H. Slee; Herbert J. Fromm; Richard B. Honzatko

A highly constrained pseudo-tetrapeptide (OC252-324) further defines a new allosteric binding site located near the center of fructose-1,6-bisphosphatase. In a crystal structure, pairs of inhibitory molecules bind to opposite faces of the enzyme tetramer. Each ligand molecule is in contact with three of four subunits of the tetramer, hydrogen bonding with the side chain of Asp187 and the backbone carbonyl of residue 71, and electrostatically interacting with the backbone carbonyl of residue 51. The ligated complex adopts a quaternary structure between the canonical R- and T-states of fructose-1,6-bisphosphatase, and yet a dynamic loop essential for catalysis (residues 52-72) is in a conformation identical to that of the T-state enzyme. Inhibition by the pseudo-tetrapeptide is cooperative (Hill coefficient of 2), synergistic with both AMP and fructose 2,6-bisphosphate, noncompetitive with respect to Mg2+, and uncompetitive with respect to fructose 1,6-bisphosphate. The ligand dramatically lowers the concentration at which substrate inhibition dominates the kinetics of fructose-1,6-bisphosphatase. Elevated substrate concentrations employed in kinetic screens may have facilitated the discovery of this uncompetitive inhibitor. Moreover, the inhibitor could mimic an unknown natural effector of fructose-1,6-bisphosphatase, as it interacts strongly with a conserved residue of undetermined functional significance.


Journal of Medicinal Chemistry | 2007

Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.

Robert I. Higuchi; Kristen L. Arienti; Francisco J. López; Neelakhanda S. Mani; Dale E. Mais; Thomas R. Caferro; Yun Oliver Long; Todd K. Jones; James P. Edwards; Lin Zhi; William T. Schrader; and Andrés Negro-Vilar; Keith B. Marschke


Archive | 2002

2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer

Kristen L. Arienti; Frank U. Axe; J. Guy Breitenbucher; Liming Huang; Alice Lee; Kelly J. Mcclure


Archive | 1999

PIPERAZINES AS INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (FBPase)

Adnan M. M. Mjalli; James Christopher Mason; Kristen L. Arienti; Kevin M. Short; Rachel D.A. Kimmich; Todd K. Jones


Archive | 2006

Substituted benzimidazoles and imidazo-[4,5]-pyridines

Michael K. Ameriks; Kristen L. Arienti; Frank U. Axe; J. Guy Breitenbucher


Archive | 2008

Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s

Michael K. Ameriks; Kristen L. Arienti; James P. Edwards; Cheryl A. Grice; Todd K. Jones; Alice Lee-Dutra; Jing Liu; Neelakandha S. Mani; Danielle K. Neff; Alvah T. Wickboldt; John J. M. Wiener


Archive | 2004

2-phenyl-benzimidazol und 2-phenyl-imidazo-4,5ü-pyridin-derivate als checkpoint-kinase-cds1 (chk2)-hemmer zur behandlung von krebs 2-phenyl-benzimidazole and 2-phenyl-imidazo-4,5ü-pyridine derivatives as checkpoint kinase cds1 (Chk2) inhibitors for treating cancer

Michael K. Ameriks; Kristen L. Arienti; Frank U. Axe; J. Guy Breitenbucher


Archive | 2004

Compuestos de benzoimidazol.

Kristen L. Arienti; J. Guy Breitenbucher; Daniel J. Buzard; James P. Edwards; Michael D. Hack; Haripada Khatuya; David E. Kindrachuk; Alice Lee; Jennifer D. Venable


Archive | 2002

2-PHENYL BENZIMIDAZOLE UND IMIDAZO-i4,5ö-PYRIDINE ALS CDS1/CHK2-INHIBITOREN UND ADJUVANTIEN IN DER CHEMOTHERAPIE ODER STRAHLUNGSTHERAPIE ZUR BEHANDLUNG VON KREBS 2-PHENYL BENZIMIDAZOLES AND IMIDAZO-i4,5ö-PYRIDINE AS CD S1 / CHK2 INHIBITORS AND ADJUVANTS IN RADIATION THERAPY OR CHEMOTHERAPY FOR THE TREATMENT OF CANCER

Kristen L. Arienti; Frank U. Axe; J. Guy Breitenbucher; Liming Huang; Alice Lee; Kelly J. Mcclure

Collaboration


Dive into the Kristen L. Arienti's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge